Literature DB >> 18160404

Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica.

Colin M Stack1, Conor R Caffrey, Sheila M Donnelly, Amritha Seshaadri, Jonathan Lowther, Jose F Tort, Peter R Collins, Mark W Robinson, Weibo Xu, James H McKerrow, Charles S Craik, Sebastian R Geiger, Rachel Marion, Linda S Brinen, John P Dalton.   

Abstract

The helminth parasite Fasciola hepatica secretes cysteine proteases to facilitate tissue invasion, migration, and development within the mammalian host. The major proteases cathepsin L1 (FheCL1) and cathepsin L2 (FheCL2) were recombinantly produced and biochemically characterized. By using site-directed mutagenesis, we show that residues at position 67 and 205, which lie within the S2 pocket of the active site, are critical in determining the substrate and inhibitor specificity. FheCL1 exhibits a broader specificity and a higher substrate turnover rate compared with FheCL2. However, FheCL2 can efficiently cleave substrates with a Pro in the P2 position and degrade collagen within the triple helices at physiological pH, an activity that among cysteine proteases has only been reported for human cathepsin K. The 1.4-A three-dimensional structure of the FheCL1 was determined by x-ray crystallography, and the three-dimensional structure of FheCL2 was constructed via homology-based modeling. Analysis and comparison of these structures and our biochemical data with those of human cathepsins L and K provided an interpretation of the substrate-recognition mechanisms of these major parasite proteases. Furthermore, our studies suggest that a configuration involving residue 67 and the "gatekeeper" residues 157 and 158 situated at the entrance of the active site pocket create a topology that endows FheCL2 with its unusual collagenolytic activity. The emergence of a specialized collagenolytic function in Fasciola likely contributes to the success of this tissue-invasive parasite.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160404      PMCID: PMC3979170          DOI: 10.1074/jbc.M708521200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Proteinases and associated genes of parasitic helminths.

Authors:  J Tort; P J Brindley; D Knox; K H Wolfe; J P Dalton
Journal:  Adv Parasitol       Date:  1999       Impact factor: 3.870

2.  wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models.

Authors:  A Perrakis; T K Sixma; K S Wilson; V S Lamzin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-07-01

3.  Lack of reversion in triclabendazole-resistant Fasciola hepatica.

Authors:  F H M Borgsteede; L Moll; P Vellema; C P H Gaasenbeek
Journal:  Vet Rec       Date:  2005-03-12       Impact factor: 2.695

4.  Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities.

Authors:  Youngchool Choe; Francesco Leonetti; Doron C Greenbaum; Fabien Lecaille; Matthew Bogyo; Dieter Brömme; Jonathan A Ellman; Charles S Craik
Journal:  J Biol Chem       Date:  2006-03-06       Impact factor: 5.157

Review 5.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

6.  Rapid interaction of cathepsin L by Z-Phe-PheCHN12 and Z-Phe-AlaCHN2.

Authors:  H Kirschke; E Shaw
Journal:  Biochem Biophys Res Commun       Date:  1981-07-30       Impact factor: 3.575

7.  Purification and characterisation of a second cathepsin L proteinase secreted by the parasitic trematode Fasciola hepatica.

Authors:  A J Dowd; A M Smith; S McGonigle; J P Dalton
Journal:  Eur J Biochem       Date:  1994-07-01

8.  Fasciola hepatica cathepsin L proteinase cleaves fibrinogen and produces a novel type of fibrin clot.

Authors:  A J Dowd; S McGonigle; J P Dalton
Journal:  Eur J Biochem       Date:  1995-08-15

Review 9.  Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.

Authors:  John P Dalton; Sandra O Neill; Colin Stack; Peter Collins; Alan Walshe; Mary Sekiya; Sean Doyle; Grace Mulcahy; Deborah Hoyle; Eric Khaznadji; Nathalie Moiré; Gerard Brennan; Angela Mousley; Natalia Kreshchenko; Aaron G Maule; Sheila M Donnelly
Journal:  Int J Parasitol       Date:  2003-09-30       Impact factor: 3.981

10.  Regulation of collagenase activities of human cathepsins by glycosaminoglycans.

Authors:  Zhenqiang Li; Yoshiyuki Yasuda; Weijie Li; Matthew Bogyo; Norman Katz; Ronald E Gordon; Gregg B Fields; Dieter Brömme
Journal:  J Biol Chem       Date:  2003-11-26       Impact factor: 5.157

View more
  40 in total

1.  41.5-kDa Cathepsin L protease from Clonorchis sinensis: expression, characterization, and serological reactivity of one excretory-secretory antigen.

Authors:  Yanwen Li; Yan Huang; Xuchu Hu; Xiaoquan Liu; Changling Ma; Junhong Zhao; Zhongdao Wu; Jin Xu; Xinbing Yu
Journal:  Parasitol Res       Date:  2012-03-10       Impact factor: 2.289

2.  Cathepsin L in the orange-spotted grouper, Epinephelus coioides: molecular cloning and gene expression after a Vibrio anguillarum challenge.

Authors:  Jing-Zhen Liang; Ying-Zhu Rao; Zhao-Rong Lun; Ting-Bao Yang
Journal:  Fish Physiol Biochem       Date:  2012-06-22       Impact factor: 2.794

3.  Lessons from high-throughput protein crystallization screening: 10 years of practical experience.

Authors:  Joseph R Luft; Edward H Snell; George T Detitta
Journal:  Expert Opin Drug Discov       Date:  2011-03-22       Impact factor: 6.098

Review 4.  Functional genes and proteins of Clonorchis sinensis.

Authors:  Tae Im Kim; Byoung-Kuk Na; Sung-Jong Hong
Journal:  Korean J Parasitol       Date:  2009-10       Impact factor: 1.341

5.  Ov-APR-1, an aspartic protease from the carcinogenic liver fluke, Opisthorchis viverrini: functional expression, immunolocalization and subsite specificity.

Authors:  Sutas Suttiprapa; Jason Mulvenna; Ngo Thi Huong; Mark S Pearson; Paul J Brindley; Thewarach Laha; Sopit Wongkham; Sasithorn Kaewkes; Banchob Sripa; Alex Loukas
Journal:  Int J Biochem Cell Biol       Date:  2008-10-19       Impact factor: 5.085

6.  An integrated transcriptomics and proteomics analysis of the secretome of the helminth pathogen Fasciola hepatica: proteins associated with invasion and infection of the mammalian host.

Authors:  Mark W Robinson; Ranjeeta Menon; Sheila M Donnelly; John P Dalton; Shoba Ranganathan
Journal:  Mol Cell Proteomics       Date:  2009-05-14       Impact factor: 5.911

7.  Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepatica.

Authors:  Mark W Robinson; Ileana Corvo; Peter M Jones; Anthony M George; Matthew P Padula; Joyce To; Martin Cancela; Gabriel Rinaldi; Jose F Tort; Leda Roche; John P Dalton
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

8.  Secreted cysteine proteases of the carcinogenic liver fluke, Opisthorchis viverrini: regulation of cathepsin F activation by autocatalysis and trans-processing by cathepsin B.

Authors:  Jittiyawadee Sripa; Thewarach Laha; Joyce To; Paul J Brindley; Banchob Sripa; Sasithorn Kaewkes; John P Dalton; Mark W Robinson
Journal:  Cell Microbiol       Date:  2010-01-11       Impact factor: 3.715

9.  SmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoni.

Authors:  Jan Dvorák; Susan T Mashiyama; Mohammed Sajid; Simon Braschi; Melaine Delcroix; Eric L Schneider; Wilson H McKerrow; Mahmoud Bahgat; Elizabeth Hansell; Patricia C Babbitt; Charles S Craik; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2009-06-02

10.  Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity.

Authors:  Iain D Kerr; Ji H Lee; Kailash C Pandey; Amanda Harrison; Mohammed Sajid; Philip J Rosenthal; Linda S Brinen
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.